Michael J. DeVit
Mersana Therapeutics (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Radiopharmaceutical Chemistry and Applications, Cancer Treatment and Pharmacology, Fungal and yeast genetics research
Most-Cited Works
- → Genetic immunization is a simple method for eliciting an immune response(1992)1,499 cited
- → Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade(2012)732 cited
- → Systematic exploration of essential yeast gene function with temperature-sensitive mutants(2011)437 cited
- → Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein(2003)425 cited
- → Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles.(1991)423 cited
- → The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae(1999)206 cited
- → Characterization of Three Related Glucose Repressors and Genes They Regulate in Saccharomyces cerevisiae(1998)180 cited
- → Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect(2021)71 cited
- → The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b(2021)47 cited